Acute Myocardial Injury in the COVID-HEART Study: Emphasizing Scars While Reassuring Scares

Article Cardiac & Cardiovascular Systems

Myocardial Involvement After Hospitalization for COVID-19 Complicated by Troponin Elevation: A Prospective, Multicenter, Observational Study

Jessica Artico et al.

Summary: This study aimed to assess the presence, nature, and extent of myocardial damage in hospitalized patients with troponin elevation and COVID-19. The study found that patients with COVID-19 and elevated cardiac troponin levels had more ventricular impairment and myocardial scar compared to the control group. However, the proportion of myocarditis was low and scar pathogenesis was diverse.

CIRCULATION (2023)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Cardiovascular Outcomes in Collegiate Athletes After SARS-CoV-2 Infection: 1-Year Follow-Up From the Outcomes Registry for Cardiac Conditions in Athletes

Bradley J. Petek et al.

CIRCULATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis

Enrico Ammirati et al.

Summary: The prevalence of acute myocarditis (AM) in COVID-19 patients is estimated to be between 2.4 and 4.1 per 1000 hospitalized patients. Most cases of AM occur in the absence of pneumonia and are often complicated by hemodynamic instability.

CIRCULATION (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS-CoV-2 Infection

Nathaniel Moulson et al.

Summary: Abnormal cTn appears to have limited diagnostic utility in return to play cardiac screening following SARS-CoV-2 infection.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection

Saurabh Rajpal et al.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Microthrombi as a Major Cause of Cardiac Injury in COVID-19 A Pathologic Study

Dario Pellegrini et al.

Summary: Analysis of heart tissue from 40 deceased COVID-19 patients revealed that microthrombi were the most common pathological cause of myocyte necrosis. Female patients with chronic kidney disease and shorter symptom onset to admission time were more likely to have myocyte necrosis. Tailored antithrombotic strategies may be useful to counteract the cardiac effects of COVID-19 infection.

CIRCULATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes

Nathaniel Moulson et al.

Summary: This study investigated the prevalence and clinical implications of COVID-19 cardiac involvement in young competitive athletes in the United States. The results showed a low prevalence of cardiac involvement and a low risk of clinical events in short-term follow-up among these athletes.

CIRCULATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study

Miroslawa Gorecka et al.

Summary: COVID-HEART is a study aiming to provide detailed characterization of cardiac involvement, repair, and recovery in relation to comorbidity, genetics, patient-reported QoL measures, and functional capacity in COVID-19 patients with elevated troponin.

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems